BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

431 related articles for article (PubMed ID: 19293843)

  • 1. Identification of the minimal combination of clinical features in probands for efficient mutation detection in the FBN1 gene.
    Stheneur C; Collod-Béroud G; Faivre L; Buyck JF; Gouya L; Le Parc JM; Moura B; Muti C; Grandchamp B; Sultan G; Claustres M; Aegerter P; Chevallier B; Jondeau G; Boileau C
    Eur J Hum Genet; 2009 Sep; 17(9):1121-8. PubMed ID: 19293843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genotype and phenotype analysis of 171 patients referred for molecular study of the fibrillin-1 gene FBN1 because of suspected Marfan syndrome.
    Loeys B; Nuytinck L; Delvaux I; De Bie S; De Paepe A
    Arch Intern Med; 2001 Nov; 161(20):2447-54. PubMed ID: 11700157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contribution of molecular analyses in diagnosing Marfan syndrome and type I fibrillinopathies: an international study of 1009 probands.
    Faivre L; Collod-Beroud G; Child A; Callewaert B; Loeys BL; Binquet C; Gautier E; Arbustini E; Mayer K; Arslan-Kirchner M; Stheneur C; Kiotsekoglou A; Comeglio P; Marziliano N; Halliday D; Beroud C; Bonithon-Kopp C; Claustres M; Plauchu H; Robinson PN; Adès L; De Backer J; Coucke P; Francke U; De Paepe A; Boileau C; Jondeau G
    J Med Genet; 2008 Jun; 45(6):384-90. PubMed ID: 18310266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of sixty-two novel and twelve known FBN1 mutations in eighty-one unrelated probands with Marfan syndrome and other fibrillinopathies.
    Arbustini E; Grasso M; Ansaldi S; Malattia C; Pilotto A; Porcu E; Disabella E; Marziliano N; Pisani A; Lanzarini L; Mannarino S; Larizza D; Mosconi M; Antoniazzi E; Zoia MC; Meloni G; Magrassi L; Brega A; Bedeschi MF; Torrente I; Mari F; Tavazzi L
    Hum Mutat; 2005 Nov; 26(5):494. PubMed ID: 16222657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FBN1 mutation screening of patients with Marfan syndrome and related disorders: detection of 46 novel FBN1 mutations.
    Attanasio M; Lapini I; Evangelisti L; Lucarini L; Giusti B; Porciani M; Fattori R; Anichini C; Abbate R; Gensini G; Pepe G
    Clin Genet; 2008 Jul; 74(1):39-46. PubMed ID: 18435798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of 29 novel and nine recurrent fibrillin-1 (FBN1) mutations and genotype-phenotype correlations in 76 patients with Marfan syndrome.
    Rommel K; Karck M; Haverich A; von Kodolitsch Y; Rybczynski M; Müller G; Singh KK; Schmidtke J; Arslan-Kirchner M
    Hum Mutat; 2005 Dec; 26(6):529-39. PubMed ID: 16220557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Qualitative and quantitative analysis of FBN1 mRNA from 16 patients with Marfan Syndrome.
    Tjeldhorn L; Amundsen SS; Barøy T; Rand-Hendriksen S; Geiran O; Frengen E; Paus B
    BMC Med Genet; 2015 Dec; 16():113. PubMed ID: 26684006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Premature termination mutations in FBN1: distinct effects on differential allelic expression and on protein and clinical phenotypes.
    Schrijver I; Liu W; Odom R; Brenn T; Oefner P; Furthmayr H; Francke U
    Am J Hum Genet; 2002 Aug; 71(2):223-37. PubMed ID: 12068374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathogenic FBN1 mutations in 146 adults not meeting clinical diagnostic criteria for Marfan syndrome: further delineation of type 1 fibrillinopathies and focus on patients with an isolated major criterion.
    Faivre L; Collod-Beroud G; Callewaert B; Child A; Loeys BL; Binquet C; Gautier E; Arbustini E; Mayer K; Arslan-Kirchner M; Kiotsekoglou A; Comeglio P; Grasso M; Beroud C; Bonithon-Kopp C; Claustres M; Stheneur C; Bouchot O; Wolf JE; Robinson PN; Adès L; De Backer J; Coucke P; Francke U; De Paepe A; Boileau C; Jondeau G
    Am J Med Genet A; 2009 May; 149A(5):854-60. PubMed ID: 19353630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comprehensive molecular screening of the FBN1 gene favors locus homogeneity of classical Marfan syndrome.
    Loeys B; De Backer J; Van Acker P; Wettinck K; Pals G; Nuytinck L; Coucke P; De Paepe A
    Hum Mutat; 2004 Aug; 24(2):140-6. PubMed ID: 15241795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dural ectasia and FBN1 mutation screening of 40 patients with Marfan syndrome and related disorders: role of dural ectasia for the diagnosis.
    Attanasio M; Pratelli E; Porciani MC; Evangelisti L; Torricelli E; Pellicanò G; Abbate R; Gensini GF; Pepe G
    Eur J Med Genet; 2013 Jul; 56(7):356-60. PubMed ID: 23684891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and molecular study of 320 children with Marfan syndrome and related type I fibrillinopathies in a series of 1009 probands with pathogenic FBN1 mutations.
    Faivre L; Masurel-Paulet A; Collod-Béroud G; Callewaert BL; Child AH; Stheneur C; Binquet C; Gautier E; Chevallier B; Huet F; Loeys BL; Arbustini E; Mayer K; Arslan-Kirchner M; Kiotsekoglou A; Comeglio P; Grasso M; Halliday DJ; Béroud C; Bonithon-Kopp C; Claustres M; Robinson PN; Adès L; De Backer J; Coucke P; Francke U; De Paepe A; Boileau C; Jondeau G
    Pediatrics; 2009 Jan; 123(1):391-8. PubMed ID: 19117906
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sensitivity of conformation sensitive gel electrophoresis in detecting mutations in Marfan syndrome and related conditions.
    Körkkö J; Kaitila I; Lönnqvist L; Peltonen L; Ala-Kokko L
    J Med Genet; 2002 Jan; 39(1):34-41. PubMed ID: 11826022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Homozygous and compound heterozygous mutations in the FBN1 gene: unexpected findings in molecular diagnosis of Marfan syndrome.
    Arnaud P; Hanna N; Aubart M; Leheup B; Dupuis-Girod S; Naudion S; Lacombe D; Milleron O; Odent S; Faivre L; Bal L; Edouard T; Collod-Beroud G; Langeois M; Spentchian M; Gouya L; Jondeau G; Boileau C
    J Med Genet; 2017 Feb; 54(2):100-103. PubMed ID: 27582083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Missense mutations in FBN1 exons 41 and 42 cause Weill-Marchesani syndrome with thoracic aortic disease and Marfan syndrome.
    Cecchi A; Ogawa N; Martinez HR; Carlson A; Fan Y; Penny DJ; Guo DC; Eisenberg S; Safi H; Estrera A; Lewis RA; Meyers D; Milewicz DM
    Am J Med Genet A; 2013 Sep; 161A(9):2305-10. PubMed ID: 23897642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of novel FBN1 and TGFBR2 mutations in 65 probands with Marfan syndrome or Marfan-like phenotypes.
    Chung BH; Lam ST; Tong TM; Li SY; Lun KS; Chan DH; Fok SF; Or JS; Smith DK; Yang W; Lau YL
    Am J Med Genet A; 2009 Jul; 149A(7):1452-9. PubMed ID: 19533785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic analysis of young adult patients with aortic disease not fulfilling the diagnostic criteria for Marfan syndrome.
    Akutsu K; Morisaki H; Okajima T; Yoshimuta T; Tsutsumi Y; Takeshita S; Nonogi H; Ogino H; Higashi M; Morisaki T
    Circ J; 2010 May; 74(5):990-7. PubMed ID: 20354336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutations of FBN1 and genotype-phenotype correlations in Marfan syndrome and related fibrillinopathies.
    Robinson PN; Booms P; Katzke S; Ladewig M; Neumann L; Palz M; Pregla R; Tiecke F; Rosenberg T
    Hum Mutat; 2002 Sep; 20(3):153-61. PubMed ID: 12203987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of thirty novel FBN1 mutations in patients with Marfan syndrome or a related fibrillinopathy.
    Biggin A; Holman K; Brett M; Bennetts B; Adès L
    Hum Mutat; 2004 Jan; 23(1):99. PubMed ID: 14695540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutation screening of the fibrillin-1 (FBN1) gene in 76 unrelated patients with Marfan syndrome or Marfanoid features leads to the identification of 11 novel and three previously reported mutations.
    Rommel K; Karck M; Haverich A; Schmidtke J; Arslan-Kirchner M
    Hum Mutat; 2002 Nov; 20(5):406-7. PubMed ID: 12402346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.